Sellas Life Sciences Group, Inc. · NASDAQ:SLS
The Vanguard Group reported a 6.70% stake in Sellas Life Sciences Group, Inc. (Schedule 13G)
Event Jun 30, 2025 · Filed Jul 29, 2025
The Vanguard Group reported a 6.70% stake in Sellas Life Sciences Group, Inc., 6,694,799 shares, as a passive investor on Jun 30, 2025. Filed Jul 29, 2025 (Schedule 13G).
- Stake
- 6.70%
- Shares
- 6,694,799
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 6.70% | 6,694,799 |
Source
Related
- Sellas Life Sciences Group, Inc.
- The Vanguard Group
- Sellas Life Sciences Group, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026
- Form 4 · Stergiou Angelos M. · Jun 18, 2026
- Schedule 13G/A · BlackRock, Inc. · Apr 24, 2026
- Schedule 13G/A · Anson Funds Management LP · Feb 17, 2026